Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase 14 |
---|
Ligand | BDBM50361468 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_797121 (CHEMBL1944479) |
---|
Kd | 0.400000±n/a nM |
---|
Citation | Millan, DS; Bunnage, ME; Burrows, JL; Butcher, KJ; Dodd, PG; Evans, TJ; Fairman, DA; Hughes, SJ; Kilty, IC; Lemaitre, A; Lewthwaite, RA; Mahnke, A; Mathias, JP; Philip, J; Smith, RT; Stefaniak, MH; Yeadon, M; Phillips, C Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease. J Med Chem54:7797-814 (2011) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase 14 |
---|
Name: | Mitogen-activated protein kinase 14 |
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 41286.76 |
Organism: | Homo sapiens (Human) |
Description: | Q16539 |
Residue: | 360 |
Sequence: | MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ
SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ
KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT
GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG
TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA
QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
|
|
|
BDBM50361468 |
---|
n/a |
---|
Name | BDBM50361468 |
Synonyms: | CHEMBL1938736 |
Type | Small organic molecule |
Emp. Form. | C30H33N7OS |
Mol. Mass. | 539.694 |
SMILES | CC(C)c1nnc2ccc(Sc3ccccc3CNC(=O)Nc3cc(nn3-c3ccccc3)C(C)(C)C)cn12 |
Structure |
|